Suppr超能文献

伴心尖部室壁瘤的心室中部梗阻性肥厚型心肌病:致心律失常性心肌病的一种重要亚型。

Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.

作者信息

Cui Li, Tse Gary, Zhao Zhiqiang, Bazoukis George, Letsas Konstantinos P, Korantzopoulos Panagiotis, Roever Leonardo, Li Guangping, Liu Tong

机构信息

Department of Cardiology, Tianjin People's Hospital, Tianjin, 300120, People's Republic of China.

Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.

出版信息

Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12638. doi: 10.1111/anec.12638. Epub 2019 Feb 9.

Abstract

Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is an uncommon type of HCM. LV apical aneurysms are present in more than 20% MVOHCM cases and has been identified as an independent predictor of potentially lethal arrhythmic events, including non-sustained or sustained ventricular tachycardia (VT), and ventricular fibrillation (VF), as well as SCD. Although the pathogenesis of LVA remains unknown, but it has been suggested that apical aneurysm may be secondary to the increased after-load and high apical pressure arising from significant pressure gradient of the midventricular obstruction. The scarred rim of the aneurysm and the adjacent areas of LV myocardial fibrosis and consequent apical oxygen-demand mismatch may be responsible for the formation of apical aneurysm. Recent electrophysiologic studies have demonstrated that the aneurysmal rim forms the primary culprit arrhythmogenic substrate for generation of monomorphic ventricular tachycardia leading to SCD, but the clinical significance of the size of aneurysm in relation to SCD remains unsettled. We summarized the clinical features of the patients with MVOHCM and apical aneurysms. Appropriate therapeutic interventions include ICD implantation, and early surgical intervention for gradient relief may be undertaken to relief the MVO.

摘要

心室中部梗阻性肥厚型心肌病(MVOHCM)是肥厚型心肌病(HCM)的一种罕见类型。超过20%的MVOHCM病例存在左心室心尖部室壁瘤,并且已被确定为潜在致命性心律失常事件的独立预测因素,这些事件包括非持续性或持续性室性心动过速(VT)、心室颤动(VF)以及心源性猝死(SCD)。尽管左心室心尖部室壁瘤(LVA)的发病机制尚不清楚,但有人提出心尖部室壁瘤可能继发于心室中部梗阻的显著压力梯度所导致的后负荷增加和心尖部高压。室壁瘤的瘢痕边缘以及左心室心肌纤维化的相邻区域和随之而来的心尖部氧需求不匹配可能是心尖部室壁瘤形成的原因。最近的电生理研究表明,室壁瘤边缘形成了导致心源性猝死的单形性室性心动过速发生的主要致心律失常基质,但室壁瘤大小与心源性猝死相关的临床意义仍未明确。我们总结了MVOHCM合并心尖部室壁瘤患者的临床特征。适当的治疗干预措施包括植入植入式心脏复律除颤器(ICD),并且可以采取早期手术干预以缓解压力阶差来解除心室中部梗阻(MVO)。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验